Targeted kill: From umbrellas to monoclonal antibodies
- 1 November 1992
- journal article
- review article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 12 (6), 391-405
- https://doi.org/10.1007/bf00918851
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- Recombinant Toxins for Cancer TreatmentScience, 1991
- A humanized monovalent CD3 antibody which can activate homologous complementEuropean Journal of Immunology, 1991
- Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxinCancer Immunology, Immunotherapy, 1991
- Bispecific Antibody That Binds Carcinoembryonic Antigen and Ricin Toxin A Chain Cytotoxic for Gastrointestinal Tract Tumor CellsJNCI Journal of the National Cancer Institute, 1990
- The influence of anti-(ricin toxin A chain) monoclonal antibodies on the pharmacokinetics of ricin toxin A chain and recombinant ricin A chain in miceCancer Immunology, Immunotherapy, 1990
- Microvascular permeability to macromolecules and its dynamic modulationAdvanced Drug Delivery Reviews, 1990
- Syngeneic anti-idiotypic antibody prevents localization of a murine monoclonal antibody in human tumour xenograftsEuropean Journal of Cancer and Clinical Oncology, 1990
- Flow Cytometric Screening of Monoclonal Antibodies for Drug or Toxin Targeting to Human CancerJNCI Journal of the National Cancer Institute, 1989
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Modification of the carbohydrate in ricin with metaperiodate — cyanoborohydride mixturesEuropean Journal of Biochemistry, 1985